ENTITY
Pixium Vision Sa

Pixium Vision Sa (PIX FP)

37
Analysis
Health CareFrance
Pixium Vision SA develops retinal implant systems. The Company develops epi-retinal and sub-retinal implant systems to treat patients who have lost their sight, with the intention of improving their vision and enabling them to lead more independent lives. Pixium Vision markets its systems throughout Europe.
more
Refresh
22 Jun 2020 14:48Issuer-paid

Pixium Vision - Restoring eyesight in advanced Dry-AMD

Pixium Vision is developing Prima 2, a potentially breakthrough wireless bionic vision system (BVS) that generates electrical impulses at the...

Share
06 Apr 2020 15:06Issuer-paid

Pixium Vision - Prima 2 18-month data shows strong promise

Pixium on 31 March reported positive 18-month follow-up data from its European feasibility study (PRIMA-FS) on the Prima 2 system in patients with...

Share
26 Mar 2020 21:58Issuer-paid

Pixium Vision - Strategy in place to mitigate COVID-19 effects

Pixium recently made prudent operational changes to contain expenditures while keeping the long-term investment thesis intact during the COVID-19...

Share
05 Mar 2020 23:00Issuer-paid

Pixium Vision - Successful Prima activation in first US patient

Pixium Vision has announced that the first patient implanted with the Prima System in its five-patient US feasibility study in atrophic dry...

Share
19 Feb 2020 21:04Issuer-paid

Pixium Vision - Wrapping up 2019 with a solid financial position

Pixium Vision’s 2019 results showed better than anticipated cost containment, as Pixium’s R&D costs were c 20% lower than expected. The company...

Share
x